Results 51 to 60 of about 192 (165)
Dexmedetomidine as a Cardioprotector in Cardiac Surgery (Review)
The literature review presents an analysis of publications on the use of a selective α2-adrenergic receptor agonist (α2-AR) dexmedetomidine as a cardioprotector in cardiosurgical interventions. It summarizes historical aspects of the introduction of α2-AR agonists in the intensive care practice.
I. A. Kozlov, T. V. Klypa, I. O. Antonov
openaire +1 more source
In a review article based on my own clinical experience of managing patients with acute myocardial injury and fulminant myocarditis, taking into account expert recommendations on the clinical treatment of myocardial damage associated with novel ...
Zayratyants O.V. +9 more
core +1 more source
According to the State Statistics Service, circulatory system diseases and malignant neoplasms take the first and second places among the causes of mortality in Ukraine. It is generally known that the basic chemotherapy principle is inhibition of mitotic
V.P. Narokha
doaj
Molecular Basis of Ischemic Post-Conditioning: DJ-1 in Cardioprotection [PDF]
Les malalties cardiovasculars són la principal causa de morbimortalitat a tot el món, essent l’infart agut de miocardi (IAM) la més prevalent. Encara que la revascularització és el tractament definitiu per a la isquèmia, paradoxalment comporta el ...
Gallinat O’Callaghan, Alex
core +2 more sources
METABOLIC CARDIOPROTECTOR THERAPY IN PEDIATRIC SPORTS MEDICINE
Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxy-pyridine succinate (“Mexicor”, EcoPharmInvest) in young athletes with stress cardiomyopathy.
L. A. Balykova +5 more
openaire +1 more source
MAIN DIRECTIONS OF DEVELOPMENTOF ANTI-AGGREGANTS AND CARDIOPROTECTORS [PDF]
T.A. Abzalilov +3 more
openaire +1 more source
The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou el Hassan, M.A. +8 more
core +1 more source
Programa de doctorat: Medicina i Ciències Biomèdiques"Tesi per compendi d'articles"L'augment constant de les Malalties Cardiovasculars Ateroscleròtides (MCVA) requereix estratègies efectives en prevenció primària.
Camps Vilaró, Anna
core +1 more source
Factors de risc cardiogènics, cardiotòxics i cardioprotectors a les organitzacions
Malaltia coronària; Factors cardiogènics; Factors cardiotòxics; Factors cardioprotectorsEnfermedad coronaria; Factores cardiogénicos; Factores cardiotóxicos; Factores cardioprotectoresCoronary heart disease; Cardiogenic factors; Cardiotoxic factors ...
Oleza-de-Serra-de-Gayeta, Rafael +6 more
core
Consumo de vino y enfermedad cardiovascular [PDF]
[spa] Introducción: Las enfermedades cardiovasculares (ECV) son la principal causa de muerte en el mundo. Los factores de riesgo incluyen una dieta poco saludable, falta de actividad física, consumo excesivo de alcohol y tabaquismo.
Borkowska, Ewa Carolina
core

